Jay K Bhama

Summary

Affiliation: University of Pittsburgh
Country: USA

Publications

  1. ncbi request reprint Reconstruction technique for a short recipient left atrial cuff during lung transplantation
    Jay K Bhama
    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Eur J Cardiothorac Surg 45:1106-7. 2014
  2. doi request reprint Heart transplantation for adults with congenital heart disease: results in the modern era
    Jay K Bhama
    Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 32:499-504. 2013
  3. doi request reprint Surgical revascularization for cardiac allograft vasculopathy: Is it still an option?
    Jay K Bhama
    Division of Cardiothoracic Transplantation, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    J Thorac Cardiovasc Surg 137:1488-92. 2009
  4. ncbi request reprint Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support
    Jay K Bhama
    Division of Cardiac Surgery, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 28:971-6. 2009
  5. ncbi request reprint Impact of abdominal complications on outcome after mechanical circulatory support
    Jay K Bhama
    Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 89:522-8; discussion 528-9. 2010
  6. pmc Early adverse events as predictors of 1-year mortality during mechanical circulatory support
    Elizabeth A Genovese
    Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    J Heart Lung Transplant 29:981-8. 2010
  7. doi request reprint Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes
    Ryan K Shields
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Heart Lung Transplant 31:1199-206. 2012
  8. doi request reprint Lung transplantation for patients with high lung allocation score: single-center experience
    Tetsuya Horai
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 93:1592-7; discussion 1597. 2012
  9. doi request reprint Donor smoking history and age in lung transplantation: a revisit
    Norihisa Shigemura
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Transplantation 95:513-8. 2013
  10. pmc Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity
    Dimitra Mitsani
    Divisions of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Antimicrob Agents Chemother 56:2371-7. 2012

Collaborators

Detail Information

Publications28

  1. ncbi request reprint Reconstruction technique for a short recipient left atrial cuff during lung transplantation
    Jay K Bhama
    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Eur J Cardiothorac Surg 45:1106-7. 2014
    ..This effectively lengthens the cuff allowing safe left atrial anastomosis. This technique has been applied in 3 patients with no technique-related complications. ..
  2. doi request reprint Heart transplantation for adults with congenital heart disease: results in the modern era
    Jay K Bhama
    Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 32:499-504. 2013
    ..The purpose of this study was to evaluate survival outcomes after heart transplantation in a contemporary cohort of adults with CHD and to identify risk factors for mortality that may help guide recipient and donor selection...
  3. doi request reprint Surgical revascularization for cardiac allograft vasculopathy: Is it still an option?
    Jay K Bhama
    Division of Cardiothoracic Transplantation, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    J Thorac Cardiovasc Surg 137:1488-92. 2009
    ..Outcomes following surgical revascularization are evaluated to determine whether surgery remains a viable therapeutic option...
  4. ncbi request reprint Clinical experience using the Levitronix CentriMag system for temporary right ventricular mechanical circulatory support
    Jay K Bhama
    Division of Cardiac Surgery, Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    J Heart Lung Transplant 28:971-6. 2009
    ..This study evaluates our clinical experience using the CentriMag (Levitronix LLC, Waltham, Mass) system for temporary mechanical RV support...
  5. ncbi request reprint Impact of abdominal complications on outcome after mechanical circulatory support
    Jay K Bhama
    Heart, Lung and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 89:522-8; discussion 528-9. 2010
    ..Most devices require abdominal wall transgression, creating a potential for abdominal complications. The incidence and impact of these relatively underreported complications are unknown...
  6. pmc Early adverse events as predictors of 1-year mortality during mechanical circulatory support
    Elizabeth A Genovese
    Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
    J Heart Lung Transplant 29:981-8. 2010
    ..Therefore, we sought to determine the impact on 1-year mortality of AEs occurring during the first 60 days of VAD support...
  7. doi request reprint Staphylococcus aureus infections in the early period after lung transplantation: epidemiology, risk factors, and outcomes
    Ryan K Shields
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA, USA
    J Heart Lung Transplant 31:1199-206. 2012
    ..Staphylococcus aureus infections among lung transplant recipients are poorly studied...
  8. doi request reprint Lung transplantation for patients with high lung allocation score: single-center experience
    Tetsuya Horai
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 93:1592-7; discussion 1597. 2012
    ..This study is a review of a single institutional experience for lung transplantation in the era of LAS...
  9. doi request reprint Donor smoking history and age in lung transplantation: a revisit
    Norihisa Shigemura
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA
    Transplantation 95:513-8. 2013
    ..Because we experienced unexpected adverse outcomes after transplant of lungs from teenaged donors with no smoking history, this study revisited the effects of donor smoking history in relation to age on transplant outcomes...
  10. pmc Prospective, observational study of voriconazole therapeutic drug monitoring among lung transplant recipients receiving prophylaxis: factors impacting levels of and associations between serum troughs, efficacy, and toxicity
    Dimitra Mitsani
    Divisions of Infectious Diseases, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Antimicrob Agents Chemother 56:2371-7. 2012
    ..Voriconazole prophylaxis was most effective at troughs of >1.5 μg/ml. A cutoff for toxicity was not identified, but troughs of >4 μg/ml were rare. The data support a target range of >1.5 to 4 μg/ml...
  11. pmc Invasive aspergillosis among heart transplant recipients is rare but causes rapid death due to septic shock and multiple organ dysfunction syndrome
    Ryan K Shields
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Scand J Infect Dis 44:982-6. 2012
    ....
  12. doi request reprint Early major neurologic complications after lung transplantation: incidence, risk factors, and outcome
    Norihisa Shigemura
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Transplantation 95:866-71. 2013
    ....
  13. doi request reprint Efficacy of extracorporeal membrane oxygenation as a bridge to lung transplantation
    Yoshiya Toyoda
    University of Pittsburgh, Pittsburgh, PA, USA
    J Thorac Cardiovasc Surg 145:1065-70; discussion 1070-1. 2013
    ..The purpose of this study is to determine whether ECMO as a bridge to lung transplantation is an acceptable option to support those in respiratory failure until donor lungs become available in the lung allocation score era...
  14. pmc Sternal-sparing approach for reoperative bilateral lung transplantation
    Jay K Bhama
    Division of Cardiac Surgery, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Interact Cardiovasc Thorac Surg 17:835-7. 2013
    ..A sternal-sparing approach for bilateral lung transplantation was recently applied to reoperative lung transplant cases and is compared with the traditional clamshell approach...
  15. doi request reprint Long-term patient and allograft outcomes of renal transplant recipients undergoing cardiac surgery
    Rodolfo V Rocha
    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA
    J Thorac Cardiovasc Surg 147:270-5. 2014
    ..This study assessed perioperative risk factors for mortality and long-term outcomes in renal transplant recipients who underwent cardiac surgery...
  16. pmc Ganciclovir-resistant cytomegalovirus infections among lung transplant recipients are associated with poor outcomes despite treatment with foscarnet-containing regimens
    Lucio R Minces
    Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA
    Antimicrob Agents Chemother 58:128-35. 2014
    ..Foscarnet-based regimens often eradicated viremia rapidly but were ineffective in the long term and limited by toxicity. ..
  17. doi request reprint Lung transplantation after lung volume reduction surgery
    Norihisa Shigemura
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, 200 Lothrop Street, Pittsburgh, PA 15213, USA
    Transplantation 96:421-5. 2013
    ..The risk-benefit tradeoffs of the combined procedure have not been thoroughly examined, although substantial information regarding LVRS has emerged...
  18. doi request reprint Extracorporeal membrane oxygenation for advanced refractory shock in acute and chronic cardiomyopathy
    Christian A Bermudez
    Department of Cardiothoracic Surgery, Cardiovascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 92:2125-31. 2011
    ....
  19. doi request reprint Extracorporeal membrane oxygenation as a bridge to lung transplant: midterm outcomes
    Christian A Bermudez
    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
    Ann Thorac Surg 92:1226-31; discussion 1231-2. 2011
    ..The impact on mid-term survival is unknown. We analyzed outcomes after lung transplant over a 19-year period in patients who received ECMO support...
  20. ncbi request reprint Delayed chest closure after lung transplantation: Techniques, outcomes, and strategies
    Norihisa Shigemura
    Division of Cardiothoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania Electronic address
    J Heart Lung Transplant 33:741-8. 2014
    ..Decision-making for DCC in the operating room remains challenging to surgeons, because the impact of DCC on outcomes after lung transplantation has not yet been fully elucidated...
  21. doi request reprint A polymorphism linked to elevated levels of interferon-γ is associated with an increased risk of cytomegalovirus disease among Caucasian lung transplant recipients at a single center
    Dimitra Mitsani
    Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA
    J Heart Lung Transplant 30:523-9. 2011
    ..Single-nucleotide polymorphisms (SNPs) associated with active cytomegalovirus (CMV) infections after lung transplantation have not been identified...
  22. doi request reprint Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events
    Brent C Lampert
    Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
    Ann Thorac Surg 97:139-46. 2014
    ..In addition, poorly controlled hypertension may increase the risk of aortic insufficiency (AI) and stroke. Blood pressure regimens after CF LVAD have not been studied and their impact on rates of AI and stroke are unknown...
  23. doi request reprint Lobar lung transplantation: a relevant surgical option in the current era of lung allocation score
    Norihisa Shigemura
    Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 96:451-6. 2013
    ..Here, we review our experience using cadaveric lobar lung transplantation as a surgical option in an attempt to decrease mortality while waiting...
  24. pmc Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation
    Elizabeth A Genovese
    Artificial Heart Program, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 88:1162-70. 2009
    ..We sought to characterize the frequency and timing of AE onset during the first 60 days of VAD support, a period during which clinical observation suggests the risk of incident AEs is high...
  25. pmc Temporal leukocyte numbers and granulocyte activation in pulsatile and rotary ventricular assist device patients
    Joshua R Woolley
    Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA, USA McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA, USA Heart and Vascular Institute, University of Pittsburgh, Pittsburgh, PA, USA
    Artif Organs 38:447-55. 2014
    ..Elevations in leukocyte activation may be related to an increased risk for infection, although the specific relationship between these phenomena in this patient group is not known. ..
  26. doi request reprint Successful prolonged ex vivo lung perfusion for graft preservation in rats
    Kentaro Noda
    Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA, USA
    Eur J Cardiothorac Surg 45:e54-60. 2014
    ..The main objective of this study was to develop a reproducible rat EVLP (R-EVLP) model that enables prolonged evaluation of the explanted lung during EVLP and successful transplantation after EVLP...
  27. doi request reprint Combined heart and liver transplantation in a patient with situs ambiguous
    Tetsuya Horai
    Division of Cardiothoracic Transplantation, Heart, Lung, and Esophageal Surgery Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15213, USA
    Ann Thorac Surg 91:600-1. 2011
    ..Combined simultaneous heart and liver transplantation was successfully performed with technical modifications, including rotated implantation and bilateral venous reconstruction...
  28. pmc Posaconazole serum concentrations among cardiothoracic transplant recipients: factors impacting trough levels and correlation with clinical response to therapy
    Ryan K Shields
    Department of Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA
    Antimicrob Agents Chemother 55:1308-11. 2011
    ..5 μg/ml were more likely to have successful outcome (P = 0.055). Age ≥ 65 years, oral administration, and absence of proton pump inhibitors were associated with higher levels of posaconazole (P = 0.006, 0.006, and 0.001, respectively)...